Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Summary

The purpose of a randomized, double-blind, placebo-controlled, 2-way crossover study is to evaluate the efficacy, safety/tolerability and pharmacokinetics of JM-010 for the treatment of subjects with Parkinson's Disease (PD) with levodopa-induced dyskinesia (LID).

Timeline

Start

2015-05

Primary completion

2015-12

Completion

2016-01

Drugs

Indications